Stay updated on Filgotinib Combo in RA Patients Inadequate Response Clinical Trial
Sign up to get notified when there's something new on the Filgotinib Combo in RA Patients Inadequate Response Clinical Trial page.

Latest updates to the Filgotinib Combo in RA Patients Inadequate Response Clinical Trial page
- Check2 days agoChange DetectedAdded PDFs for the Study Protocol and SAP, included IPD sharing information, and expanded related MeSH terms and topics relevant to the trial.SummaryDifference100%

- Check9 days agoChange DetectedKey documents such as Statistical Analysis Plan, Study Protocol, and IPD sharing information appear to have been removed from the study's Documents section. This change alters what users can review about the trial's methodology and data-sharing practices.SummaryDifference16%

- Check16 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a CMS/version update rather than any changes to the study details.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedThe page shows a new Revision tag (v3.6.3) replacing the previous v3.6.0, indicating a small update to the page's underlying version, without altering the displayed study details.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page now displays the recruitment status No longer looking for participants and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment label formatting is adjusted and a Revision: v3.6.0 note is included.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page displays a new Revision: v3.5.5 and removes several related-topic links (Rheumatoid arthritis, related topics:, MedlinePlus Genetics) from the related topics section.SummaryDifference0.1%

Stay in the know with updates to Filgotinib Combo in RA Patients Inadequate Response Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib Combo in RA Patients Inadequate Response Clinical Trial page.